RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.34% | -45.57% | -75.69% | -41.85% | -16.41% |
| Total Depreciation and Amortization | 25.06% | 11.40% | 2.95% | -8.64% | -30.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.38% | 22.16% | 50.38% | 55.68% | 61.33% |
| Change in Net Operating Assets | 610.96% | 42.11% | 93.69% | 46.61% | -1.68% |
| Cash from Operations | 226.89% | -35.16% | -6.69% | 8.47% | 11.11% |
| Capital Expenditure | -41.98% | -9.13% | 0.84% | 29.60% | 42.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.25% | -102.17% | 109.01% | 122.07% | 134.89% |
| Cash from Investing | -57.47% | -118.57% | 104.75% | 117.01% | 128.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 74.47% | 38.46% | 57.45% | 57.38% | 43.37% |
| Issuance of Common Stock | -64.37% | -79.14% | -97.15% | -96.94% | -95.46% |
| Repurchase of Common Stock | 75.73% | 72.44% | 72.44% | 56.76% | 56.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -58.05% | -83.43% | -98.03% | -98.49% | -96.95% |
| Foreign Exchange rate Adjustments | -116.67% | -173.33% | -- | 133.33% | -45.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.37% | -269.32% | -126.33% | -54.02% | 88.69% |